These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11118904)

  • 1. Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen.
    Andersson C; Liljeström P; Ståhl S; Power UF
    FEMS Immunol Med Microbiol; 2000 Dec; 29(4):247-53. PubMed ID: 11118904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
    Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
    J Infect Dis; 2001 May; 183(9):1395-8. PubMed ID: 11294672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.
    Xu J; Ding Y; Yang Y
    Viral Immunol; 2008 Dec; 21(4):483-9. PubMed ID: 19115938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challenge.
    Plotnicky-Gilquin H; Cyblat-Chanal D; Goetsch L; Lacheny C; Libon C; Champion T; Beck A; Pasche H; Nguyen TN; Bonnefoy JY; Bouveret-le-Cam N; Corvaïa N
    Virology; 2002 Nov; 303(1):130-7. PubMed ID: 12482664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
    Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ
    Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection.
    Kumar M; Behera AK; Lockey RF; Zhang J; Bhullar G; De La Cruz CP; Chen LC; Leong KW; Huang SK; Mohapatra SS
    Hum Gene Ther; 2002 Aug; 13(12):1415-25. PubMed ID: 12215263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of truncated G protein delivered by live attenuated Salmonella as a vaccine against respiratory syncytial virus.
    Tian P; Xu D; Huang Z; Meng F; Fu J; Wei H; Chen T
    Microb Pathog; 2018 Feb; 115():299-303. PubMed ID: 29306006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.
    de Waal L; Power UF; Yüksel S; van Amerongen G; Nguyen TN; Niesters HG; de Swart RL; Osterhaus AD
    Vaccine; 2004 Feb; 22(8):915-22. PubMed ID: 15161068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice.
    Goetsch L; Plotnicky-Gilquin H; Aubry JP; De-Lys P; Haeuw JF; Bonnefoy JY; Nguyen NT; Corvaïa N; Velin D
    Vaccine; 2001 Jul; 19(28-29):4036-42. PubMed ID: 11427280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus: reverse genetics and vaccine strategies.
    Collins PL; Murphy BR
    Virology; 2002 May; 296(2):204-11. PubMed ID: 12069519
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced immune protection by a liposome-encapsulated recombinant respiratory syncytial virus (RSV) vaccine using immunogenic lipids from Deinococcus radiodurans.
    Huang Y; Anderson R
    Vaccine; 2002 Feb; 20(11-12):1586-92. PubMed ID: 11858866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.
    Ward TM; Traina-Dorge V; Davis KA; Gray WL
    J Gen Virol; 2008 Mar; 89(Pt 3):741-750. PubMed ID: 18272766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.
    Harcourt JL; Anderson LJ; Sullender W; Tripp RA
    Vaccine; 2004 Jun; 22(17-18):2248-60. PubMed ID: 15149784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.